261 related articles for article (PubMed ID: 30222697)
1. Vaccine Impact on Long-term Trends in Invasive Bacterial Disease in New Zealand Children.
Walls T; Cho V; Martin N; Williman J; Brunton C
Pediatr Infect Dis J; 2018 Oct; 37(10):1041-1047. PubMed ID: 30222697
[TBL] [Abstract][Full Text] [Related]
2. Prevention of invasive diseases: strategies to increase vaccination coverage in children and adolescents.
Zoppi G; Trucchi C
J Prev Med Hyg; 2012 Jun; 53(2):125-9. PubMed ID: 23240175
[TBL] [Abstract][Full Text] [Related]
3. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
Trucchi C; Zoppi G
J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
[TBL] [Abstract][Full Text] [Related]
4. Experience of vaccination against invasive bacterial diseases in Veneto region (north east Italy).
Russo F; Pozza F; Napoletano G; Zanella F; Baldovin T; Lazzari R; Cocchio S; Baldo V
J Prev Med Hyg; 2012 Jun; 53(2):113-5. PubMed ID: 23240172
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines.
Ciruela P; Martínez A; Izquierdo C; Hernández S; Broner S; Muñoz-Almagro C; Domínguez À;
Hum Vaccin Immunother; 2013 Mar; 9(3):681-91. PubMed ID: 23303166
[TBL] [Abstract][Full Text] [Related]
6. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.
Martin NG; Sadarangani M; Pollard AJ; Goldacre MJ
Lancet Infect Dis; 2014 May; 14(5):397-405. PubMed ID: 24631222
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-preventable severe morbidity and mortality caused by meningococcus and pneumococcus: A population-based study in France.
Lorton F; Chalumeau M; Assathiany R; Martinot A; Bucchia M; Roué JM; Bourgoin P; Chantreuil J; Boussicault G; Gaillot T; Saulnier JP; Caillon J; Levy C; Cohen R; Gras-Le Guen C; Launay E
Paediatr Perinat Epidemiol; 2018 Sep; 32(5):442-447. PubMed ID: 30170336
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.
Eton V; Schroeter A; Kelly L; Kirlew M; Tsang RSW; Ulanova M
Int J Infect Dis; 2017 Dec; 65():27-33. PubMed ID: 28951105
[TBL] [Abstract][Full Text] [Related]
9. Sustaining immunity after immunization against encapsulated bacteria.
Blanchard-Rohner G; Pollard AJ
Hum Vaccin; 2008; 4(4):309-12. PubMed ID: 18398302
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand.
Arnold R; Galloway Y; McNicholas A; O'Hallahan J
Vaccine; 2011 Sep; 29(40):7100-6. PubMed ID: 21803101
[TBL] [Abstract][Full Text] [Related]
11. Sustained reductions of invasive infectious disease following general infant Haemophilus influenzae type b and pneumococcal vaccination in a Swedish Arctic region.
Johansson Kostenniemi U; Norman D; Sellin M; Silfverdal SA
Acta Paediatr; 2019 Oct; 108(10):1871-1878. PubMed ID: 31025393
[TBL] [Abstract][Full Text] [Related]
12. Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines.
Omeñaca F; Arístegui J; Tejedor JC; Moreno-Perez D; Ruiz-Contreras J; Merino JM; Muro Brussi M; Sánchez-Tamayo T; Castro Fernandez J; Cabanillas L; Peddiraju K; Mesaros N; Miller JM
Pediatr Infect Dis J; 2011 Nov; 30(11):e216-24. PubMed ID: 21747321
[TBL] [Abstract][Full Text] [Related]
13. [Advances in vaccines and invasive disease in children].
Moraga Llop FA
Rev Esp Quimioter; 2001 Dec; 14(4):319-30. PubMed ID: 11856977
[No Abstract] [Full Text] [Related]
14. Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction.
Sigaúque B; Vubil D; Sozinho A; Quintó L; Morais L; Sacoor C; Carvalho MG; Verani JR; Alonso PL; Roca A
J Pediatr; 2013 Jul; 163(1 Suppl):S19-24. PubMed ID: 23773589
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
[TBL] [Abstract][Full Text] [Related]
16. The incidence of pediatric invasive Haemophilus influenzae and pneumococcal disease in Chiba prefecture, Japan before and after the introduction of conjugate vaccines.
Ishiwada N; Hishiki H; Nagasawa K; Naito S; Sato Y; Chang B; Sasaki Y; Kimura K; Ohnishi M; Shibayama K
Vaccine; 2014 Sep; 32(42):5425-31. PubMed ID: 25131741
[TBL] [Abstract][Full Text] [Related]
17. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
[TBL] [Abstract][Full Text] [Related]
18. Vaccinating premature infants in a Special Care Baby Unit in the UK: results of a prospective, non-inferiority based, pragmatic case series study.
Baxter D; Ghebrehewet S; Welfare W; Ding DC
Hum Vaccin; 2010 Jun; 6(6):512-20. PubMed ID: 20421709
[TBL] [Abstract][Full Text] [Related]
19. Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom.
Ladhani SN
Clin Ther; 2012 Feb; 34(2):385-99. PubMed ID: 22244051
[TBL] [Abstract][Full Text] [Related]
20. Hospitalization rates and outcome of invasive bacterial vaccine-preventable diseases in Tuscany: a historical cohort study of the 2000-2016 period.
Chiappini E; Inturrisi F; Orlandini E; de Martino M; de Waure C
BMC Infect Dis; 2018 Aug; 18(1):396. PubMed ID: 30103691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
